115 related articles for article (PubMed ID: 38844945)
1. Nocturnal hypoxemic burden and micro- and macrovascular disease in patients with type 2 diabetes.
Driendl S; Stadler S; Arzt M; Zeman F; Heid IM; Baumert M
Cardiovasc Diabetol; 2024 Jun; 23(1):195. PubMed ID: 38844945
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Nocturnal Hypoxemic Burden in Patients Undergoing Elective Coronary Artery Bypass Grafting Surgery.
Tafelmeier M; Blagoeva VG; Trum M; Hegner P; Floerchinger B; Camboni D; Creutzenberg M; Zeman F; Schmid C; Maier LS; Wagner S; Linz D; Baumert M; Arzt M
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893039
[No Abstract] [Full Text] [Related]
3. Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men.
Baumert M; Immanuel SA; Stone KL; Litwack Harrison S; Redline S; Mariani S; Sanders P; McEvoy RD; Linz D
Eur Heart J; 2020 Jan; 41(4):533-541. PubMed ID: 30590586
[TBL] [Abstract][Full Text] [Related]
4. Transvenous phrenic nerve stimulation for the treatment of central sleep apnea reduces episodic hypoxemic burden.
Baumert M; Immanuel S; McKane S; Linz D
Int J Cardiol; 2023 May; 378():89-95. PubMed ID: 36841294
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal hypoxemic burden during positive airway pressure treatment across different central sleep apnea etiologies.
Linz D; Malfertheiner MV; Werner N; Lerzer C; Gfüllner F; Linz B; Zeman F; McEvoy RD; Arzt M; Baumert M
Sleep Med; 2021 Mar; 79():62-70. PubMed ID: 33482454
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
7. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study.
Zhao S; Yu S; Chi C; Fan X; Tang J; Ji H; Teliewubai J; Zhang Y; Xu Y
Cardiovasc Diabetol; 2019 Jul; 18(1):95. PubMed ID: 31345238
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
[TBL] [Abstract][Full Text] [Related]
9. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
10. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
[TBL] [Abstract][Full Text] [Related]
11. Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea.
Oldenburg O; Costanzo MR; Germany R; McKane S; Meyer TE; Fox H
J Cardiovasc Transl Res; 2021 Apr; 14(2):377-385. PubMed ID: 32789619
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Tanaka A; Shimabukuro M; Okada Y; Sugimoto K; Kurozumi A; Torimoto K; Hirai H; Node K;
Cardiovasc Diabetol; 2020 Jun; 19(1):85. PubMed ID: 32534578
[TBL] [Abstract][Full Text] [Related]
13. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
15. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
16. Associations between macrovascular and renal microvascular dysfunction in type 2 diabetes and non-diabetes: the HELIUS study.
Hayfron-Benjamin CF; Amoah AGB; Maitland-van der Zee AH; Moll van Charante EP; Galenkamp H; van den Born BJ; Agyemang C
Microvasc Res; 2021 Jul; 136():104162. PubMed ID: 33705823
[TBL] [Abstract][Full Text] [Related]
17. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
18. Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study.
Wang C; Zhang W; Wang Y; Wan H; Chen Y; Xia F; Zhang K; Wang N; Lu Y
Cardiovasc Diabetol; 2019 Jul; 18(1):97. PubMed ID: 31366359
[TBL] [Abstract][Full Text] [Related]
19. Association of C-peptide with diabetic vascular complications in type 2 diabetes.
Wang Y; Wan H; Chen Y; Xia F; Zhang W; Wang C; Fang S; Zhang K; Li Q; Wang N; Lu Y
Diabetes Metab; 2020 Feb; 46(1):33-40. PubMed ID: 31026551
[TBL] [Abstract][Full Text] [Related]
20. Intermittent hypoxia is an independent marker of poorer glycaemic control in patients with uncontrolled type 2 diabetes.
Torrella M; Castells I; Gimenez-Perez G; Recasens A; Miquel M; Simó O; Barbeta E; Sampol G
Diabetes Metab; 2015 Sep; 41(4):312-318. PubMed ID: 25662841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
